Paradigm Biopharmaceuticals Ltd.’s (PAR) Moving Averages Convergence Divergence (MACD) indicator is 0.01, suggesting Paradigm Biopharmaceuticals Ltd. is a Sell.

Paradigm Biopharmaceuticals Ltd.’s (PAR) 20-Day exponential moving average is 0.42, while Paradigm Biopharmaceuticals Ltd.’s (PAR) share price is AU$0.46, making it a Buy.

Paradigm Biopharmaceuticals Ltd.’s (PAR) 50-Day exponential moving average is 0.39, while Paradigm Biopharmaceuticals Ltd.’s (PAR) share price is AU$0.46, making it a Buy.

Paradigm Biopharmaceuticals Ltd. (PAR) Pivot Points

Jan 22, 2025, 04:42 AM

Classic

0.38

0.40

0.42

0.43

0.45

0.47

0.48

Fibonacci

0.40

0.41

0.42

0.43

0.45

0.47

Pivot points are a technical analysis tool used by traders to identify potential support and resistance levels in financial markets. Pivot points are calculated based on the previous day's high, low, and close prices, and are used to help traders identify levels at which the price may reverse or continue to trend.

Paradigm Biopharmaceuticals Ltd. (PAR) Moving Averages

Jan 22, 2025, 04:42 AM

MA5

0.43Buy

0.44Buy

MA10

0.43Buy

MA20

0.41Buy

0.42Buy

MA50

0.39Buy

MA100

0.31Buy

0.34Buy

MA200

0.28Buy

0.32Buy

Paradigm Biopharmaceuticals Ltd.’s (PAR) 10-Day exponential moving average is 0.43, while Paradigm Biopharmaceuticals Ltd.’s (PAR) share price is AU$0.46, making it a Buy.

Paradigm Biopharmaceuticals Ltd.’s (PAR) 100-Day exponential moving average is 0.34, while Paradigm Biopharmaceuticals Ltd.’s (PAR) share price is AU$0.46, making it a Buy.

Paradigm Biopharmaceuticals Ltd.’s (PAR) stock price is AU$0.46 and Paradigm Biopharmaceuticals Ltd.’s (PAR) 50-day simple moving average is 0.39, creating a Buy signal.

Paradigm Biopharmaceuticals Ltd.’s (PAR) stock price is AU$0.46 and Paradigm Biopharmaceuticals Ltd.’s (PAR) 100-day simple moving average is 0.31, creating a Buy signal.

Paradigm Biopharmaceuticals Ltd.’s (PAR) stock price is AU$0.46 and Paradigm Biopharmaceuticals Ltd.’s (PAR) 200-day simple moving average is 0.28, creating a Buy signal.

Paradigm Biopharmaceuticals Ltd. (PAR) Technical Indicators

Jan 22, 2025, 04:42 AM

RSI (14)

57.20

Neutral

STOCH (9,6)

45.53

Neutral

STOCHRSI (14)

55.13

Neutral

MACD (12,26)

0.01

Sell

ADX (14)

23.54

Neutral

Williams %R

-30.77

Buy

CCI (14)

107.15

Sell

ATR (14)

0.04

Ultimate Oscillator

44.04

Neutral

ROC

16.67

Buy

Paradigm Biopharmaceuticals Ltd.’s (PAR) Relative Strength Index (RSI) is 57.20, creating a Neutral signal.

Paradigm Biopharmaceuticals Ltd.’s (PAR) Trend Strength Indicator (ADX) is 23.54, creating a Neutral signal.

Paradigm Biopharmaceuticals Ltd.’s (PAR) Commodity Channel Index (CCI) is 107.15, creating a Sell signal.

Paradigm Biopharmaceuticals Ltd.’s (PAR) Price Rate of Change (ROC) is 16.67, creating a Buy signal.

Technical Analysis Screener >

Technical Analysis Screener.

Customize your technical analysis to fit your
unique trading strategy with a flexible screener

Try it Now!

FAQ

Is PAR a Buy, Hold, or Sell?

Based on PAR’s technical indicators, PAR is a Strong Buy.

What is PAR’s RSI (14)?

PAR’s RSI (14) is 57.20, which suggests PAR is a Neutral.

What is PAR’s MACD?

PAR’s MACD is 0.01, which suggests PAR is a Sell.

What is PAR’s 5-day moving average?

PAR’s 5-day moving average is 0.43, which suggests PAR is a Buy.

What is PAR’s 20-day moving average?

PAR 20-day moving average is 0.41, which suggests PAR is a Buy.

What is PAR’s 50-day moving average?

PAR’s 50-day moving average is 0.39, which suggests PAR is a Buy.

What is PAR’s 200-day moving average?

PAR’s 200-day moving average is 0.28, which suggests PAR is a Buy.

What is PAR’s Williams % R (14)?

PAR’s Williams % R (14) is -30.77, which suggests PAR is a Buy.

What is PAR’s CCI (14)?

PAR’s CCI (14) is 107.15, which suggests PAR is a Sell.

What is the share price of Paradigm Biopharmaceuticals Ltd.?

Paradigm Biopharmaceuticals Ltd.'s share price is N/AAU$.

Become an Expert with TipRanks Premium

What am I Missing?

Make informed decisions based on Top Analysts' activity

Know what industry insiders are buying

Get actionable alerts from top Wall Street Analysts

Find out before anyone else which stock is going to shoot up

Get powerful stock screeners & detailed portfolio analysis

Subscribe Now See Plans & Pricing